Karp JE - Search Results

1

Hypoalbuminemia as a prognostic biomarker for higher mortality and treatment complications in acute myeloid leukemia.

Doucette K, Percival ME, Williams L, Kandahari A, Taylor A, Wang S, Ahn J, Karp JE, Lai C. Doucette K, et al. Among authors: karp je. Hematol Oncol. 2021 Dec;39(5):697-706. doi: 10.1002/hon.2925. Epub 2021 Sep 9. Hematol Oncol. 2021. PMID: 34499366

2

Cure of acute myelocytic leukemia in adults: a reality.

Geller RB, Saral R, Karp JE, Santos GW, Burke PJ. Geller RB, et al. Among authors: karp je. Leukemia. 1990 May;4(5):313-5. Leukemia. 1990. PMID: 2201825 Review.

3

A two-step timed sequential treatment for acute myelocytic leukemia.

Geller RB, Burke PJ, Karp JE, Humphrey RL, Braine HG, Tucker RW, Fox MG, Zahurak M, Morrell L, Hall KL, et al. Geller RB, et al. Among authors: karp je. Blood. 1989 Oct;74(5):1499-506. Blood. 1989. PMID: 2676014 Free article. Clinical Trial.

4

Management of infections in patients with acute leukemia.

Sarkodee-Adoo CB, Merz WG, Karp JE. Sarkodee-Adoo CB, et al. Among authors: karp je. Oncology (Williston Park). 2000 May;14(5):659-66, 671-2; discussion 672-7. Oncology (Williston Park). 2000. PMID: 10853459 Free article. Review.

5

A phase II study of timed sequential therapy of acute myelogenous leukemia (AML) for patients over the age of 60: two cycle timed sequential therapy with topotecan, ara-C and mitoxantrone in adults with poor-risk AML.

Bolaños-Meade J, Guo C, Gojo I, Karp JE. Bolaños-Meade J, et al. Among authors: karp je. Leuk Res. 2004 Jun;28(6):571-7. doi: 10.1016/j.leukres.2003.10.026. Leuk Res. 2004. PMID: 15120933 Clinical Trial.

6

Durable molecular remissions with a single cycle of timed sequential consolidation chemotherapy in acute promyelocytic leukemia.

Gore SD, Smith BD, Gojo I, Grever M, Kaufmann SH, Letendre L, Leonard DG, Marcucci G, Miller CB, Morris L, Piantadosi S, Prior T, Stock W, Karp JE. Gore SD, et al. Among authors: karp je. Am J Hematol. 2005 Jun;79(2):119-27. doi: 10.1002/ajh.20354. Am J Hematol. 2005. PMID: 15929100 Free article.

7

Sequential flavopiridol, cytosine arabinoside, and mitoxantrone: a phase II trial in adults with poor-risk acute myelogenous leukemia.

Karp JE, Smith BD, Levis MJ, Gore SD, Greer J, Hattenburg C, Briel J, Jones RJ, Wright JJ, Colevas AD. Karp JE, et al. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4467-73. doi: 10.1158/1078-0432.CCR-07-0381. Clin Cancer Res. 2007. PMID: 17671131 Clinical Trial.

8

Phase II trial of tipifarnib as maintenance therapy in first complete remission in adults with acute myelogenous leukemia and poor-risk features.

Karp JE, Smith BD, Gojo I, Lancet JE, Greer J, Klein M, Morris L, Levis MJ, Gore SD, Wright JJ, Garrett-Mayer E. Karp JE, et al. Clin Cancer Res. 2008 May 15;14(10):3077-82. doi: 10.1158/1078-0432.CCR-07-4743. Clin Cancer Res. 2008. PMID: 18483374 Free PMC article. Clinical Trial.

9

New agents in acute myeloid leukemia: beyond cytarabine and anthracyclines.

Fathi AT, Karp JE. Fathi AT, et al. Among authors: karp je. Curr Oncol Rep. 2009 Sep;11(5):346-52. doi: 10.1007/s11912-009-0047-x. Curr Oncol Rep. 2009. PMID: 19679009 Free PMC article. Review.

10

New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia.

Tiu RV, Gondek LP, O'Keefe CL, Huh J, Sekeres MA, Elson P, McDevitt MA, Wang XF, Levis MJ, Karp JE, Advani AS, Maciejewski JP. Tiu RV, et al. Among authors: karp je. J Clin Oncol. 2009 Nov 1;27(31):5219-26. doi: 10.1200/JCO.2009.21.9840. Epub 2009 Sep 21. J Clin Oncol. 2009. PMID: 19770377 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

290 results

Search Page